Bottom Line Inc

What to Do When the “Little Pink Pill” Won’t Light Your Fire…


Is complete abstinence from alcohol…blood pressure so low you pass out…and fighting sleep all day really worth better sex only once every two months? That’s about the best women who take Addyi (flibanserin)—aka the “little pink pill”—can expect.

A recent meta-analysis of eight clinical trials involving 6,000 women with low sexual desire disorder further confirmed that the drug is a poor performer. Compared to placebo, women who took the drug increased “satisfying sexual events” by…wait for it…0.49 per month, on average.

There is a better way—actually, many better ways. Discover drug-free tips for women to perk up a fading libido and feel sexier.

And since it takes two to tango, you may also want to tell your man, if he’s concerned about performance, to start eating blueberries.

Source:  Source: Study titled “Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systemic Review and Meta-Analysis” by researchers at Erasmus University Medical Center, Groene Hart Hospital and University of Amsterdam, all in the Netherlands, and Vrije Universiteit Brussel, Belgium, published in JAMA. Date: March 14, 2016 Publication: Bottom Line Health
Keep Scrolling for related content View Comments